51 JFK Parkway, Short Hills, NJ 07078
DEA Defense · Registration · Inspection · Order to Show Cause · Immediate Suspension · Criminal

DEA Defense Attorneys

An ISO can stop dispensing in 24 hours. The hearing is months away.

DEA's diversion control posture has tightened materially since 2022. Registration applications face heightened scrutiny. Routine inspections produce Orders to Show Cause. Immediate Suspension Orders can stop a pharmacy or practice from dispensing within 24 hours, and the administrative hearing on the merits is months away.

The criminal track runs in parallel through DOJ when the inspection record supports prosecution. Health Law Alliance defends DEA registrants across pharmacies, physicians, distributors, and manufacturers. In 2025, we filed a federal court action that lifted an Immediate Suspension Order against a pharmacy client, naming the DEA Administrator as defendant.

5,000+
Federal & State Healthcare Matters
100+
Combined Years at DOJ, DEA & Healthcare Co's
24 hrs
Window From ISO Service to Operational Stop
24/7
Emergency Response, ISO to Federal Court
DEA Defense Hotline · Direct Line
(800) 345 - 4125
Speak with counsel who has filed federal court action against DEA. Privileged. Available 24/7.
Former officials from the agencies investigating your matter
U.S. Department of Justice
DOJ
FBI
FBI
HHS OIG
HHS-OIG
DEA
DEA
OptumRx
OptumRx
McKesson
McKesson
NAMFCU
NAMFCU
U.S. Treasury
Treasury
The Stakes
A DEA matter affects three things at once: dispensing, registration, and personal liberty

An Immediate Suspension Order stops dispensing today. An Order to Show Cause threatens the registration. A criminal referral threatens personal liberty. The defense posture has to address all three on different timelines.

  • Immediate Suspension Order: dispensing stops in 24 hours
  • Registration loss is industry exit
  • Criminal exposure under 21 USC § 841 et seq
Federal government building
Federal enforcement
01
Immediate Suspension Order: dispensing stops in 24 hours

DEA can issue an ISO on a finding that continued registration poses an "imminent danger to public health or safety." Once served, the registrant must stop dispensing controlled substances within 24 hours. The administrative hearing on the merits is typically 3 to 6 months away. Federal court action under 21 USC § 877 is the only mechanism that can lift the ISO before the hearing.

Operational Stop
02
Registration loss is industry exit

A revoked DEA registration cannot be transferred, sold, or restored without going through the full reapplication and DEA review process. For a pharmacy, registration loss ends controlled substance dispensing across the entire schedule list. For a prescriber, it ends the ability to write controlled substance prescriptions. Restoration applications face heightened scrutiny that can take 1 to 3 years to resolve.

Registration Exposure
03
Criminal exposure under 21 USC § 841 et seq

DEA inspection findings often produce criminal referrals to DOJ. The Controlled Substances Act carries up to 20 years per count for distribution outside the course of professional practice, with mandatory minimums in some patterns. Personal liability for owners, prescribers, and pharmacists-in-charge is the rule, not the exception. The criminal track often runs in parallel with the administrative track.

Criminal Exposure
Why DEA Defense Is Different
Four structural features make DEA matters fundamentally distinct from any other healthcare proceeding

DEA runs its own administrative process under its own evidentiary standards. The clock, the forum, and the rules of engagement are different from PBM audits, CMS reviews, or DOJ civil matters. Defense counsel that does not know the DEA process loses procedural ground in the first 24 hours.

Factor 01
ISOs run on DEA's clock, not yours.
An Immediate Suspension Order takes effect on service. The registrant has no advance notice, no opportunity to be heard before the suspension, and no automatic stay pending appeal. The first procedural opportunity is the administrative hearing, typically 3 to 6 months out. Federal court action under 21 USC § 877 is the only mechanism that can produce relief on a faster timeline.
Factor 02
OTSC plus administrative hearing differs from federal court.
An Order to Show Cause initiates DEA's administrative process before an Administrative Law Judge (ALJ). The ALJ's recommended decision is reviewed by the DEA Administrator, who issues the Final Order. Federal court review of the Final Order is then available under 21 USC § 877. The procedural posture has its own discovery rules, evidentiary standards, and timing different from any federal civil or criminal court matter.
Factor 03
Parallel criminal track via DOJ.
DEA inspection findings frequently produce criminal referrals to the local U.S. Attorney's Office. The criminal track runs in parallel with the administrative track. A statement made in the administrative proceeding can become evidence in the criminal case. The defense posture has to coordinate across both tracks from day one or risk locking in admissions that hurt the criminal defense later.
Factor 04
Heightened scrutiny on new registrations.
DEA registration application reviews have become materially more rigorous since 2022. New applications, change-of-ownership applications, and renewal applications from registrants with any prior compliance history all face heightened review. A pending or recent DEA matter against the registrant or an affiliate can pause or deny an otherwise routine application.
"An Immediate Suspension Order takes effect on service. The defense that lifts it begins on the same day."
Protect Your Pharmacy Now →
The HLA DEA Defense Process
A four-stage protocol built for the DEA's clock and DEA's forum

Our bench includes a former federal prosecutor and senior healthcare-company counsel. We have filed federal court action against the DEA Administrator to lift an Immediate Suspension Order, drafted OTSC responses for hearings before DEA Administrative Law Judges, and coordinated DEA defense with parallel DOJ criminal matters. This is the protocol.

  • ISO triage and federal court action
  • OTSC response and ALJ preparation
  • DEA engagement and resolution
  • Parallel criminal defense
Conference room
Where defense is built
01
ISO triage and federal court action

Within 24 hours of an Immediate Suspension Order: evaluate the basis cited (controlled substance dispensing pattern, recordkeeping deficiencies, alleged diversion), reconstruct the inventory reconciliation record DEA will rely on, confirm whether federal court action under 21 USC § 877 is available, and prepare emergency filings. We have lifted an ISO through federal court action and we know what the pleading needs to say.

02
OTSC response and ALJ preparation

For Orders to Show Cause: draft and file the response within the statutory window, conduct DEA-side discovery, prepare witnesses, and present the case before the Administrative Law Judge. The ALJ proceeding has its own evidentiary standards distinct from federal court, and the record built at the ALJ stage is the record the DEA Administrator will review.

03
DEA engagement and resolution

Many DEA matters resolve through negotiated outcomes before the Final Order issues: corrective action plans, memorandums of agreement, voluntary registration modifications. Direct engagement with DEA Diversion Control and the relevant U.S. Attorney's Office often produces resolution that protects the registration even where the inspection findings are partially substantiated.

04
Parallel criminal defense

When the DEA matter produces a criminal referral to DOJ: white-collar defense engagement runs in parallel with the administrative track. Pre-charge advocacy, grand jury subpoena response, target letter response, and federal court defense if charges issue. Our former-federal-prosecutor bench coordinates the criminal defense with the DEA administrative defense as one matter.

Common DEA Investigation Triggers
The six patterns that draw a DEA inspection or Order to Show Cause

DEA's Diversion Control Division ranks registrants on multiple analytics metrics, then deploys field investigators to the highest-risk locations. The following patterns are the most common predicates for a routine inspection that escalates.

01
High-volume controlled substance dispensing.
Pharmacies and prescribers in the top decile of controlled substance volume (especially Schedule II opioids, benzodiazepines, and stimulants) face elevated inspection frequency. The top decile cutoff varies by state and specialty, but the analytics ranking is consistent.
02
Out-of-state prescriber concentration.
Pharmacies that dispense a high percentage of prescriptions written by out-of-state prescribers, or by prescribers not in the local geography of the patients, often draw DEA review. Telehealth controlled substance prescribing increases this exposure.
03
Cash-pay percentage above DEA threshold.
High percentages of cash-pay controlled substance dispensing (versus insurance-billed) trigger DEA red-flag analysis. The pattern is associated in DEA's analytics with diversion risk regardless of legitimate cash-pay populations the pharmacy may serve.
04
CSOS or inventory discrepancies.
Controlled Substance Ordering System (CSOS) discrepancies, biennial inventory issues, or DEA Form 222 problems can produce inspection findings even on routine reviews. Recordkeeping gaps under 21 CFR 1304 are the most common cited basis for OTSC.
05
PBM or CMS audit referral to DEA.
PBM audit findings on controlled substance claims, or CMS contractor findings on Medicare Part D controlled substance billing, can be referred to DEA for parallel review. The audit becomes the predicate for a DEA inspection that the registrant did not anticipate.
06
State board investigation or complaint.
A state board of pharmacy or medical board investigation that involves controlled substances often triggers parallel DEA review. The state record becomes part of DEA's evidence at the federal level. State board defense and DEA defense have to coordinate.
Recent DEA Defense Outcomes
Representative Case Results

Outcomes are summarized for confidentiality. Client names, precise geography, and identifying facts are redacted.

Federal government building ISO Lifted
Federal Court Action Lifts Immediate Suspension Order Against Pharmacy.

Pharmacy received an Immediate Suspension Order from the DEA. Health Law Alliance filed federal court action under 21 USC § 877, naming the DEA Administrator as defendant. The court action produced relief that lifted the ISO and allowed the pharmacy to resume controlled substance dispensing while the administrative matter proceeded.

Federal court · Pharmacy · 2025
Federal courtroom Indictment Dismissed
Federal Healthcare Fraud Indictment Against Physician Collapses.

Solo physician faced a multi-count federal indictment that included controlled substance counts. Health Law Alliance filed responsive motions, built the procedural record, and challenged the government's theory; the indictment collapsed before trial. Criminal DEA matters and federal healthcare fraud indictments share procedural posture and the same defense framework applies.

Northeast · Solo physician · 2025
US Capitol DOJ Declination
DOJ Declines Criminal Prosecution of Alleged $6M Fraud.

Healthcare company faced alleged $6M healthcare fraud allegations across multiple federal districts after a parallel agency referral. After Health Law Alliance's pre-charge presentation to prosecutors and factual rebuttal of the government's theory, DOJ declined criminal prosecution. Pre-charge advocacy is also the highest-leverage move when a DEA matter produces a criminal referral.

National scope · Healthcare company · 2024

Attorney advertising. Prior results do not guarantee a similar outcome. Case summaries are generalized for confidentiality and are not a substitute for legal advice on your specific matter.

The Firm
We Used to Work for Them.
Now We Fight for You.
Client Reviews
What Clients Say
  1. Anthony's background as a former federal prosecutor and executive for major healthcare companies provided a level of expertise and insight that made all the difference. His deep understanding of healthcare law, particularly in litigation and compliance matters, helped navigate complex legal issues with ease.
DEA Defense FAQ
Frequently Asked Questions

Seven questions that come up on almost every first call. The answers below are general; specific situations require privileged consultation.

What is the difference between an Immediate Suspension Order and an Order to Show Cause? +
An Immediate Suspension Order (ISO) is an emergency suspension of a DEA registration under 21 USC § 824(d). The ISO takes effect on service. The registrant cannot dispense, prescribe, or handle controlled substances from that moment. DEA must show "imminent danger to the public health or safety" to issue an ISO. An Order to Show Cause (OTSC) is the administrative charging document that proposes revocation or denial of the registration and triggers a hearing before a DEA administrative law judge. An OTSC, on its own, does not stop dispensing. An ISO and an OTSC are often issued together, in which case the ISO stops dispensing immediately and the OTSC proceeds to an ALJ hearing on whether the registration should be revoked. The defenses, the procedural posture, and the relief available are different for each.
Should I voluntarily surrender my DEA registration if asked? +
No, not without privileged advice. DEA Diversion Investigators sometimes present a DEA Form 104 (Voluntary Surrender of Controlled Substances Privileges) during an inspection or interview and frame surrender as a way to "resolve" the matter. A voluntary surrender is treated as a final administrative action. The registrant gives up the right to a hearing, the right to challenge the underlying allegations, and the practical ability to obtain a new registration in the future. State boards, PBMs, hospital credentialing committees, and Medicare all treat a DEA surrender as adverse action with downstream consequences. Decline to sign a Form 104 in the moment, request to speak with counsel, and let DEA proceed with whatever administrative process they intend to file.
What triggers a DEA inspection of my pharmacy or practice? +
Common triggers in 2026 include: high per-prescriber or per-patient controlled substance dispensing volume relative to peers; concentration of out-of-state prescribers writing controlled substances filled at the pharmacy; cash-pay percentage on controlled substances above the DEA's internal benchmark; CSOS, biennial inventory, or DEA Form 222 discrepancies; referrals from a PBM audit or a CMS contractor audit that flag controlled substance patterns; state pharmacy board investigations that DEA receives notice of; and a tip from a former employee, prescriber, or competitor. Cyclic inspections, scheduled every two to three years for most registrants, also occur on a routine basis. The trigger matters because it shapes what DEA is looking for and what the realistic exposure is.
Can I keep dispensing controlled substances while an OTSC hearing is pending? +
If the OTSC was issued without a paired Immediate Suspension Order, the registration generally remains valid through the ALJ hearing and the Administrator's final order. The registrant continues to dispense under the existing registration. If the OTSC is paired with an ISO, dispensing stops on service of the ISO regardless of the timing of the OTSC hearing. The hearing on the ISO and the hearing on the OTSC are often consolidated, but the ISO's practical effect is independent of the hearing schedule. The registrant who wants to keep dispensing during the proceeding has two options: file an action in federal district court under 21 USC § 877 challenging the ISO, or negotiate a memorandum of agreement with DEA that lifts the ISO subject to specified conditions. Both routes require immediate action.
How does a DEA action affect my state pharmacy or medical license? +
State boards monitor DEA actions and frequently open parallel proceedings. An ISO, an OTSC, a voluntary surrender, or a final revocation order is reportable to most state boards under either the registrant's own reporting obligation or the board's monitoring of DEA's public registration database. State board investigations can result in suspension or revocation of the underlying state pharmacy license, the medical license, or the prescriber's controlled substance authority issued by the state. State board proceedings have their own evidentiary standards, hearing procedures, and timelines. The defense strategy must coordinate the DEA proceeding with the state board proceeding from the start to avoid admissions or stipulations in one forum that constrain the defense in the other.
When does a DEA matter become a criminal case? +
DEA refers matters to the Department of Justice when the diversion investigation produces evidence of intentional unlawful distribution rather than recordkeeping or registration issues. Common referral patterns include: dispensing without a legitimate medical purpose under 21 USC § 841; conspiracy with prescribers under 21 USC § 846; maintaining a drug-involved premises under 21 USC § 856; obtaining controlled substances by fraud under 21 USC § 843; and money laundering tied to controlled substance proceeds under 18 USC § 1956. Criminal exposure runs up to 20 years per count under § 841 for Schedule II controlled substances. The administrative case (ISO, OTSC, registration revocation) and the criminal case proceed on separate but related tracks. Statements made in the administrative case can be used in the criminal case. A registrant who learns DEA has involved DOJ should retain criminal defense counsel immediately and coordinate the administrative defense with the criminal defense.
Can I sue DEA in federal court to lift an Immediate Suspension Order? +
Yes, in the right matter. 21 USC § 877 provides federal district court jurisdiction over DEA registration actions in specified circumstances, including challenges to Immediate Suspension Orders that allege DEA exceeded its statutory authority or failed to meet the "imminent danger" standard required for an ISO. A § 877 action is an aggressive posture and is not appropriate in every matter. When the facts support it, federal court action can produce a temporary restraining order or preliminary injunction that lifts the ISO and restores dispensing while the administrative proceeding continues. We have used this posture to obtain reinstated dispensing for a registrant within days of an ISO that would otherwise have required months to resolve through the standard administrative track. The decision to sue DEA is a litigation decision that turns on the strength of the underlying defense and the realistic timeline for a § 877 ruling in the relevant district.
Speak with DEA Defense Counsel Today

An Immediate Suspension Order takes effect on service — the defense that lifts it begins on the same day

Before DEA serves the ISO, before the OTSC hearing locks in the administrative posture, before DOJ files the criminal complaint, have a privileged conversation with attorneys who defend DEA matters across registration, inspection, ISO, OTSC, and parallel criminal exposure. Free, confidential, no retainer.

"DEA served the ISO on a Friday afternoon. By Monday morning, Health Law Alliance had filed in federal district court under 21 USC § 877. The court issued a TRO that lifted the ISO within ten days. We were dispensing again before the administrative hearing was even scheduled. The standard administrative track would have taken months." - Pharmacy owner, independent retail pharmacy (anonymized client, 2025)
DEA at your door? An ISO stops dispensing in 24 hours.